Vaccines Market Scenario
Growing government support for vaccine development, high prevalence of infectious diseases and technological advancements in the field of vaccines are some of the major factors propelling the vaccines market globally. Furthermore, rising focus on immunization programs is also one of the factor propelling the growth of vaccines market. However, high cost of vaccine development is one of the major factor expected to hamper the global growth of the market.
Vaccines Market Segmentation
The vaccines market is segmented by Type, Technology, Disease, Route, Patient and geography. The Type studied in the vaccines market are Monovalent and Multivalent Vaccines. Various technology studied in the vaccines market are Conjugate vaccines, Inactivated and subunit vaccines, live attenuated vaccines, Recombinant vaccines and Toxoid vaccines. Furthermore, the Disease segment comprises of Pneumococcal Disease, DTP, Influenza, HPV, Meningococcal Disease, Polio, Hepatitis, Rotavirus, MMR, Varicella, Herpes Zoster and Other Disease Indications. Likewise, the Route segment includes Intramuscular and Subcutaneous Administration, Oral Administration and Other Routes of Administration. In addition, the Patient studied in the report are Pediatric and Adult. Based on Geography, the Vaccines Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Vaccines Market by Geography
Based on geography, the vaccines market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global vaccines market. Major drivers include high prevalence of infectious diseases and increasing investments by government and non-government organizations for vaccine development. U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and availability of skilled professionals.
Vaccines Market Key Players
Some of the major players operating in the global vaccines market includes Astrazeneca, Bavarian Nordic, Bharat Biotech, Biological E, CSL Limited, Daiichi Sankyo Company, Limited, Emergent Biosolutions, Inc, Glaxosmithkline PLC, Johnson & Johnson, Merck & Co., Inc, Mitsubishi Tanabe Pharma Corporation, Panacea Biotec, LTD, Pfizer, Inc, Sanofi Pasteur SA and Serum Institute of India Pvt., LTD. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market. Players are implementing strategies, such as long-term contracts with diagnostic clinics and laboratories and discount pricing for bulk purchases.
Vaccines Market Report Key Benefits